Biogen Inc. buy BMO Capital Markets
Start price
26.07.23
/
50%
€243.00
Target price
26.07.24
€313.55
Performance (%)
-15.64%
Price
09.05.24
€205.00
Summary
This prediction is currently active. The price of Biogen Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -15.64%. This prediction currently runs until 26.07.24. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biogen Inc. | 3.119% | 3.119% |
iShares Core DAX® | 4.015% | 2.971% |
iShares Nasdaq 100 | 2.755% | 0.503% |
iShares Nikkei 225® | -0.826% | -5.057% |
iShares S&P 500 | 2.330% | 0.720% |
Comments by BMO_Capital_Markets for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at BMO Capital Markets from $357.00 to $347.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat